Exodus Point Capital Management, LP Lantheus Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$51.07 - $68.26 $9.52 Million - $12.7 Million	-186,479 Reduced 81.21%	43,156 $2.69 Million
Q3 2023 Nov 09, 2023	BUY	$60.27 - $90.75 $5.42 Million - $8.16 Million	89,879 Added 64.31%	229,635 $16 Million
Q2 2023 Aug 10, 2023	BUY	$82.41 - $99.65 $8.03 Million - $9.71 Million	97,393 Added 229.9%	139,756 $11.7 Million
Q1 2023 May 11, 2023	SELL	$47.76 - $82.86 $1.36 Million - $2.37 Million	-28,577 Reduced 40.28%	42,363 $3.5 Million
Q4 2022 Feb 13, 2023	BUY	$48.76 - $77.67 $2.27 Million - $3.62 Million	46,554 Added 190.9%	70,940 $3.62 Million
Q3 2022 Nov 10, 2022	BUY	$61.42 - $86.29 $1.5 Million - $2.1 Million	24,386 New	24,386 $1.72 Million

495

67.2M

1.19M

829K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.38B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.